Stocks / NASDAQ / Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc.

Our Opinion

Tenax Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“ODM-108 blocks pain in several animal models of pain.” (Page 50) Read the full document

Company Description

Tenax Therapeutics, Inc., incorporated on April 17, 2008, is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company’s main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure. [Source: Reuters]

Company Website: